Longitudinal Cognitive Assessment by BoCA

Multiple Sclerosis Clinical Trial

— BoCA  

Official title:

Longitudinal Cognitive Assessment by BoCA

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04114994
• Other study ID #: BoCA001
• Status: Recruiting
• Start date: October 1, 2019
• Est. completion date: October 1, 2029

Study information

• Verified date: January 2023
• Source: Alzheimer's Light LLC
• Contact: ANDREY VYSHEDSKIY, Ph.D.
• Phone: 6174338577
• Email: vysha[@]bu.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

Description:

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not- repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals. BoCA includes eight subtests in the following domains: Memory/Immediate Recall, Memory/Delayed Recall, Executive function/ Visuospatial, Executive function/ Mental rotation, Attention, Mental math, Language/Prefrontal Synthesis, and Orientation. The maximum total score is 30. Higher score indicates better cognitive performance. After BoCA is completed, the domain scores and total score are provided immediately. Users will also receive an email with the link to the full report with progress charts. The BoCA evaluation can help doctors figure out if an underlying condition is causing a patient's cognitive decline. Many treatable conditions such as sleep disorders, mood problems, heavy metal accumulation, as well as lack of movement and social interactions can affect memory and thinking. Our goal is to reduce barriers for patients to receive the testing that may benefit their treatment and health through the use of digital technology.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: October 1, 2029
• Est. primary completion date: October 1, 2029
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

age 50 or older Exclusion Criteria: younger than 50 years

Related Conditions & MeSH terms

• Alzheimer Disease
• Aphasia, Primary Progressive
• Cognitive Dysfunction
• Dementia
• Dementia, Vascular
• Frontotemporal Dementia
• Mild Cognitive Impairment
• Multiple Sclerosis
• Parkinson Disease
• Pick Disease of the Brain
• TBI
• Vascular Dementia

Intervention

Diagnostic Test:
• Boston Cognitive Assessment (BoCA)
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals. BoCA includes eight subtests in the following domains: Memory/Immediate Recall, Memory/Delayed Recall, Executive function/ Visuospatial, Executive function/ Mental rotation, Attention, Mental math, Language/Prefrontal Synthesis, and Orientation. The maximum total score is 30. Higher score indicates better cognitive performance. After BoCA is completed, the domain scores and total score are provided immediately. Users will also receive an email with the link to the full report with progress charts.

Locations

Country	Name	City	State
United States	Andrey Vyshedskiy	Miami	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Alzheimer's Light LLC

Country where clinical trial is conducted

United States, 

References & Publications (1)

Foster NL, Bondi MW, Das R, Foss M, Hershey LA, Koh S, Logan R, Poole C, Shega JW, Sood A, Thothala N, Wicklund M, Yu M, Bennett A, Wang D. Quality improvement in neurology: Mild cognitive impairment quality measurement set. Neurology. 2019 Oct 15;93(16):705-713. doi: 10.1212/WNL.0000000000008259. Epub 2019 Sep 18. No abstract available. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Boston Cognitive Assessment (BoCA)	The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.	through study completion, an average of 1 year

External Links

•   BoCA website